Stock Analyses
Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.
All sectors 6,479
Financial Services 1,900
Healthcare 1,116
Technology 1,079
Industrials 668
Consumer Cyclical 490
Basic Materials 337
Consumer Defensive 248
Communication Services 213
Utilities 183
Energy 165
Real Estate 80
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
BBSI
Fairly valued
BARRETT BUSINESS SERVICES INC
Price$32.80
Model IV$28.52
P/IV1.14
Premium +15%
Return to IV: -13.0%
Owner yield 3.8%
10-yr IRR 6.3% · moderate
Market implies +7.6%/yr
vs model +8.3% · in line
BBT
Deeply overvalued
Beacon Financial Corp
Price$30.83
Model IV$7.96
P/IV3.65
Premium +287%
Return to IV: -74.2%
Market implies +9.3%/yr
vs model -10.0% · above model
BBUC
Valuation N/A
Brookfield Business Corp
Price$25.70
Model IV—
P/IV—
BBVA
Valuation N/A
BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Price$28.36
Model IV—
P/IV—
BBW
Deeply undervalued
BUILD-A-BEAR WORKSHOP INC
Price$24.44
Model IV$47.81
P/IV0.78
Discount 49%
Return to IV: +95.6%
Owner yield 11.8%
10-yr IRR 26.0% · moderate
Market implies -1.9%/yr
vs model +11.0% · below model
BBWI
Deeply undervalued
Bath & Body Works, Inc.
Price$17.40
Model IV$54.18
P/IV0.37
Discount 68%
Return to IV: +211.4%
Owner yield 20.0%
10-yr IRR 33.5% · moderate
Market implies -11.6%/yr
vs model +7.0% · below model
BBY
Deeply overvalued
BEST BUY CO INC
Price$92.85
Model IV$65.74
P/IV0.17
Premium +41%
Return to IV: -29.2%
Owner yield 5.6%
10-yr IRR 7.1% · steady
Market implies +7.2%/yr
vs model +2.7% · above model
BC
Fairly valued
BRUNSWICK CORP
Price$67.55
Model IV$71.16
P/IV1.18
Discount 5%
Return to IV: +5.3%
Owner yield 8.3%
10-yr IRR 16.3% · moderate
Market implies +5.1%/yr
vs model +7.0% · in line
BCAB
Valuation N/A
BioAtla, Inc.
Price$1.79
Model IV—
P/IV—
Market implies +68.1%/yr
vs model +15.0% · above model
BCAC
Valuation N/A
Brookline Capital Acquisition Corp II
Price$4.93
Model IV—
P/IV—
BCAL
Deeply overvalued
California BanCorp CA
Price$21.80
Model IV$8.46
P/IV2.25
Premium +158%
Return to IV: -61.2%
BCAR
Valuation N/A
D. Boral ARC Acquisition I Corp.
Price$2.93
Model IV—
P/IV—
BCARU
Valuation N/A
BCARU
Price$5.16
Model IV—
P/IV—
BCARW
Valuation N/A
BCARW
Price$0.48
Model IV—
P/IV—
BCAT
Valuation N/A
BlackRock Capital Allocation Term Trust
Price$14.34
Model IV—
P/IV—
BCAX
Valuation N/A
Bicara Therapeutics Inc.
Price$22.64
Model IV—
P/IV—
BCBP
Deeply undervalued
BCB BANCORP INC
Price$8.72
Model IV$16.97
P/IV1.36
Discount 49%
Return to IV: +94.6%
BCC
Deeply undervalued
BOISE CASCADE Co
Price$75.69
Model IV$108.14
P/IV0.17
Discount 30%
Return to IV: +42.9%
Owner yield 8.1%
10-yr IRR 10.2% · steady
Market implies -8.3%/yr
vs model +0.0% · below model
BCDA
Valuation N/A
BioCardia, Inc.
Price$1.17
Model IV—
P/IV—
Market implies +63.9%/yr
vs model +15.0% · above model
BCE
Fairly valued
BCE INC
Price$22.90
Model IV$25.92
P/IV0.88
Discount 12%
Return to IV: +13.2%
Owner yield 11.1%
10-yr IRR 14.9% · steady
Market implies -4.2%/yr
vs model -0.3% · below model
BCG
Deeply undervalued
Binah Capital Group, Inc.
Price$1.28
Model IV$3.08
P/IV0.52
Discount 58%
Return to IV: +140.2%
Market implies -11.1%/yr
vs model +7.1% · below model
BCGWW
Valuation N/A
Binah Capital Group, Inc.
Price$0.09
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +6.3% · below model
BCH
Valuation N/A
BANK OF CHILE
Price$40.80
Model IV—
P/IV—
BCHT
Deeply overvalued
Birchtech Corp.
Price$1.76
Model IV$1.13
P/IV1.53
Premium +56%
Return to IV: -36.1%
Market implies +0.6%/yr
vs model +7.9% · below model
BCIC
Deeply undervalued
BCP Investment Corp
Price$7.03
Model IV$130.53
P/IV0.06
Discount 95%
Return to IV: +1,756.8%
Market implies -47.5%/yr
vs model +3.8% · below model
BCML
Fairly valued
BayCom Corp
Price$30.10
Model IV$26.28
P/IV1.17
Premium +15%
Return to IV: -12.7%
BCO
Deeply undervalued
BRINKS CO
Price$106.12
Model IV$180.03
P/IV0.58
Discount 41%
Return to IV: +69.6%
Owner yield 8.4%
10-yr IRR 19.0% · moderate
Market implies +0.6%/yr
vs model +9.9% · below model
BCPC
Deeply overvalued
BALCHEM CORP
Price$167.05
Model IV$105.43
P/IV1.49
Premium +58%
Return to IV: -36.9%
Market implies +10.9%/yr
vs model +6.2% · above model
BCRX
Deeply undervalued
BIOCRYST PHARMACEUTICALS INC
Price$8.68
Model IV$50.33
P/IV0.18
Discount 83%
Return to IV: +479.8%
Market implies -5.6%/yr
vs model +25.0% · below model
BCS
Valuation N/A
BARCLAYS PLC
Price$24.87
Model IV—
P/IV—
BCSF
Fairly valued
Bain Capital Specialty Finance, Inc.
Price$11.09
Model IV$10.95
P/IV1.22
Premium +1%
Return to IV: -1.3%
Market implies -4.5%/yr
vs model -1.6% · in line
BCSS
Valuation N/A
Bain Capital GSS Investment Corp.
Price$10.29
Model IV—
P/IV—
BCTX
Valuation N/A
BriaCell Therapeutics Corp.
Price$4.21
Model IV—
P/IV—
BCTXL
Valuation N/A
BriaCell Therapeutics Corp.
Price$1.15
Model IV—
P/IV—
BCTXZ
Valuation N/A
BriaCell Therapeutics Corp.
Price$0.17
Model IV—
P/IV—
BCV
Valuation N/A
BANCROFT FUND LTD
Price$23.69
Model IV—
P/IV—
BCX
Valuation N/A
BlackRock Resources & Commodities Strategy Trust
Price$12.47
Model IV—
P/IV—
BCYC
Valuation N/A
BICYCLE THERAPEUTICS PLC
Price$3.65
Model IV—
P/IV—
Market implies +18.5%/yr
vs model +18.2% · in line
BDC
Deeply overvalued
BELDEN INC.
Price$110.92
Model IV$61.32
P/IV1.71
Premium +81%
Return to IV: -44.7%
Owner yield 4.8%
10-yr IRR 6.4% · steady
Market implies +12.3%/yr
vs model +4.5% · above model
BDCI
Valuation N/A
BTC Development Corp.
Price$10.16
Model IV—
P/IV—
BDCIU
Valuation N/A
BTC Development Corp.
Price$10.30
Model IV—
P/IV—
BDCIW
Valuation N/A
BTC Development Corp.
Price$0.43
Model IV—
P/IV—
BDCX
Valuation N/A
UBS AG
Price$20.21
Model IV—
P/IV—
BDCZ
Valuation N/A
UBS AG
Price$15.11
Model IV—
P/IV—
BDJ
Valuation N/A
BlackRock Enhanced Equity Dividend Trust
Price$9.59
Model IV—
P/IV—
BDL
Undervalued
FLANIGANS ENTERPRISES INC
Price$42.64
Model IV$58.00
P/IV0.59
Discount 26%
Return to IV: +36.0%
Owner yield 1.3%
10-yr IRR -5.1% · moderate
Market implies +1.7%/yr
vs model +9.8% · below model
BDMD
Deeply overvalued
Baird Medical Investment Holdings Ltd
Price$1.05
Model IV$0.41
P/IV3.61
Premium +155%
Return to IV: -60.7%
Market implies +6.8%/yr
vs model +2.0% · above model
BDMDW
Valuation N/A
Baird Medical Investment Holdings Ltd
Price$0.04
Model IV—
P/IV—
Market implies -37.5%/yr
vs model +2.0% · below model
BDN
Deeply overvalued
BRANDYWINE REALTY TRUST
Price$2.90
Model IV$1.27
P/IV2.43
Premium +128%
Return to IV: -56.1%
BDRX
Valuation N/A
Biodexa Pharmaceuticals Plc
Price$0.73
Model IV—
P/IV—
Market implies +150.0%/yr
vs model +15.0% · above model
BDRY
Deeply overvalued
Amplify Commodity Trust
Price$15.72
Model IV$4.03
P/IV3.21
Premium +290%
Return to IV: -74.4%
BDSX
Deeply overvalued
BIODESIX INC
Price$29.20
Model IV$16.65
P/IV0.98
Premium +75%
Return to IV: -43.0%
Market implies +2.3%/yr
vs model +12.9% · below model
BDTX
Deeply undervalued
Black Diamond Therapeutics, Inc.
Price$1.96
Model IV$4.09
P/IV0.54
Discount 52%
Return to IV: +108.6%
Market implies -6.4%/yr
vs model +10.0% · below model
BDX
Valuation N/A
BECTON DICKINSON & CO
Price$180.94
Model IV—
P/IV—
Owner yield 5.1%
10-yr IRR 7.7% · steady
Market implies +3.5%/yr
vs model +5.4% · in line
BE
Valuation N/A
Bloom Energy Corp
Price$265.63
Model IV—
P/IV—
Market implies +48.8%/yr
vs model +21.9% · above model
BEAG
Valuation N/A
Bold Eagle Acquisition Corp.
Price$10.70
Model IV—
P/IV—
BEAGR
Valuation N/A
Bold Eagle Acquisition Corp.
Price$0.18
Model IV—
P/IV—
BEAGU
Valuation N/A
Bold Eagle Acquisition Corp.
Price$11.22
Model IV—
P/IV—
BEAM
Valuation N/A
Beam Therapeutics Inc.
Price$24.95
Model IV—
P/IV—
Market implies +43.8%/yr
vs model +28.1% · above model
BEAT
Valuation N/A
HeartBeam, Inc.
Price$0.40
Model IV—
P/IV—